26 related articles for article (PubMed ID: 19836782)
1. Cell signaling in kidney cancer.
Adam R
J Urol; 2009 Dec; 182(6):2555-6. PubMed ID: 19836771
[No Abstract] [Full Text] [Related]
2. Lord of the rings: a promising novel treatment for renal cell carcinoma?
Johansson M
Eur Urol; 2011 May; 59(5):745-6. PubMed ID: 21276657
[No Abstract] [Full Text] [Related]
3. Comment on "Decoy receptor 3 expression in AsPC-1 human pancreatic adenocarcinoma cells via the phosphatidylinositol 3-kinase-, Akt-, and NF-kappa B-dependent pathway".
Wang W; Sun W; Zhang L
J Immunol; 2009 Aug; 183(4):2203; author reply 2203-4. PubMed ID: 19661264
[No Abstract] [Full Text] [Related]
4. Editorial comment.
Oya M
J Urol; 2009 Dec; 182(6):2577. PubMed ID: 19836782
[No Abstract] [Full Text] [Related]
5. Phosphatidylinositol-3-kinase/Akt signaling pathway and kidney cancer, and the therapeutic potential of phosphatidylinositol-3-kinase/Akt inhibitors.
Porta C; Figlin RA
J Urol; 2009 Dec; 182(6):2569-77. PubMed ID: 19836781
[TBL] [Abstract][Full Text] [Related]
6. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.
Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L
Adv Enzyme Regul; 2008; 48():2-9. PubMed ID: 18280812
[No Abstract] [Full Text] [Related]
7. Targeting renal cell carcinoma.
Chowdhury S; Pandha H
Clin Oncol (R Coll Radiol); 2006 Sep; 18(7):511-2. PubMed ID: 16969979
[No Abstract] [Full Text] [Related]
8. New therapies after failure of angiogenesis inhibitors.
Escudier B
Clin Adv Hematol Oncol; 2009 Aug; 7(8):512-4. PubMed ID: 19927977
[No Abstract] [Full Text] [Related]
9. [Renal cell carcinoma in a horseshoe kidney: a case report].
Ibuki N; Uehara H; Komura K; Koyama K; Inamoto T; Segawa N; Tuji M; Azuma H; Katsuoka Y
Hinyokika Kiyo; 2009 Oct; 55(10):611-3. PubMed ID: 19926945
[TBL] [Abstract][Full Text] [Related]
10. [DNA and microRNA microarray technologies in diagnostics and prediction for patients with renal cell carcinoma].
Slabý O; Svoboda M; Michálek J; Vyzula R
Klin Onkol; 2009; 22(5):202-9. PubMed ID: 19886357
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]